Natrixam 1,5 mg/5 mg tablete s prilagođenim oslobađanjem
| Name | Natrixam 1,5 mg/5 mg tablete s prilagođenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-053397374 |
| Active Substance | indapamid amlodipinbesilat |
| Composition | jedna tableta sadrži 1,5 mg indapamida i 6,935 mg amlodipinbesilata što odgovara 5 mg amlodipina |
| Pharmaceutical Form | tableta s prilagođenim oslobađanjem |
| Manufacturer | Les Laboratoires Servier Industrie, Gidy, Francuska Servier (Ireland) Industries Ltd., Arklow, Co. Wicklow, Irska Anpharm Przedsiebiorstwo Farmaceutyczne S.A., Varšava, Poljska Laboratorios Servier S.L., Madrid, Španjolska Egis Pharmaceuticals Private Limited Company (PLC), Kormend, Mađarska Egis Pharmaceuticals Private Limited Company (PLC), Budimpešta, Mađarska |
| Marketing Authorisation Holder | Servier Pharma d.o.o., Ulica Grge Tuškana 37, Zagreb, Hrvatska |
| Marketing Authorisation Date | 02.07.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/794 |
| Registration Number | 381-12-01/30-20-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C08GA02 |
| Marketing status | trajni prekid opskrbe |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
